http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021017315-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F222-1025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D133-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-301 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-30 |
| filingDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64fd8ea3351221330e473765bc73c30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf252bf18a00c5fa06d6bab22d52354 |
| publicationDate | 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021017315-A1 |
| titleOfInvention | Cured product, optical member, lens, and compound |
| abstract | The present invention provides a cured product obtained by curing a curable composition including a compound represented by General Formula 1, in which a birefringence Δn (587 nm) is 0.00≤Δn (587 nm)≤0.01. n Pol 1 -Sp 1 -L 1 -Ar-L 2 -Sp 2 -Pol 2 (General Formula 1)n n In the formula, Ar represents a divalent group containing a ring structure selected from the group consisting of a quinoxaline ring and a quinazoline ring; L 1 and L 2 each represent a single bond, —O—, —OC(═O)—, —OC(═O)O—, —OC(═O)NH—, and the like; Sp 1 and Sp 2 each represent a single bond or a divalent linking group; Pol 1 and Pol 2 each represent a hydrogen atom or a polymerizable group; and the compound represented by General Formula 1 has at least one polymerizable group. The cured product of the present invention has a small Abbe number (νd) and a large partial dispersion ratio (θg, F), and is therefore useful for production of optical members. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11674082-B2 |
| priorityDate | 2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 341.